UPDATE: Jefferies Starts Dendreon (DNDN) at Underperform, Sees 35% Downside
Tweet Send to a FriendGet Alerts DNDN Hot Sheet
Price: $3.99 -2.21%
Rating Summary:
5 Buy, 15 Hold, 12 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
5 Buy, 15 Hold, 12 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade DNDN Now!
Jefferies initiates coverage on Dendreon Corp. (Nasdaq: DNDN) with an Underperform rating and $5 price target, suggesting 35% downside.
The firm comments, "Our analysis and survey results show Provenge to be relegated to a niche position by competition in a lucrative market with anemic sales. Near-term volatility is expected with limited sales visibility on current commercialization snags. Despite mid-term profitability, DNDN’s potentially meager cash flows are accompanied by debt overhang. Initiate with an Underperform and $5 PT."
For an analyst ratings summary and ratings history on Dendreon Corp. click here. For more ratings news on Dendreon Corp. click here.
Shares of Dendreon Corp. closed at $7.70 yesterday, with a 52 week range of $6.46-$42.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "Our analysis and survey results show Provenge to be relegated to a niche position by competition in a lucrative market with anemic sales. Near-term volatility is expected with limited sales visibility on current commercialization snags. Despite mid-term profitability, DNDN’s potentially meager cash flows are accompanied by debt overhang. Initiate with an Underperform and $5 PT."
For an analyst ratings summary and ratings history on Dendreon Corp. click here. For more ratings news on Dendreon Corp. click here.
Shares of Dendreon Corp. closed at $7.70 yesterday, with a 52 week range of $6.46-$42.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Wedbush Starts Owens Corning (OC) at Outperform
- Deutsche Bank Starts Quintiles (Q) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Jefferies & CoLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

